Mazdutide for Adults With Prediabetes: A Randomized, Double-Blind, Placebo-Controlled Trial (DREAM-PRE)

A phase 4 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 150 participants.

Also called NCT07654062

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; double masking; primary purpose prevention
Phase
Phase 4
Enrolled
  • 150 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT07654062
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Not yet recruiting (from the registry)

Technical summary

Registry record NCT07654062. Randomized; double masking; primary purpose prevention. Start 2026-07 (anticipated); primary completion 2028-06 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Mazdutide for Adults With Prediabetes: A Randomized, Double-Blind, Placebo-Controlled Trial (DREAM-PRE)
Acronym
DREAM-PRE
Condition
Prediabetes
Condition
Impaired Fasting Glucose
Condition
Impaired Glucose Tolerance (Prediabetes)
Intervention (Drug)
Mazdutide
Intervention (Drug)
Placebo
Intervention (Behavioral)
Standardized Lifestyle Intervention
Lead sponsor
Shandong Provincial Hospital (class: other government)
Collaborator
Innovent Biologics, Inc. (class: other)

Record details

Record id
cardio:ct-nct07654062
Content hash
1f030be2a9a5b05a328ed4ca3fe6bc9636ddc8938df6ec552a7dfacf731cd02e